Literature DB >> 16185742

Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.

Rama Rao Amara1, Chris Ibegbu, Francois Villinger, David C Montefiori, Sunita Sharma, Pragati Nigam, Yongxian Xu, Harold M McClure, Harriet L Robinson.   

Abstract

Here, we study immune responses in four DNA/MVA-vaccinated macaques following an SHIV-89.6P challenge and a subsequent CD8 cell depletion. Both post-challenge and post-depletion peaks of viremia contracted with the expansion, or re-emergence, of CD8 T cells. Post-depletion, CD8 cells expanded in the presence of higher levels of neutralizing Ab and CD4 help than post-challenge and had superior maturational characteristics as measured by expression of the anti-apoptotic protein Bcl-2, the IL-7 receptor CD127 and co-production of IFN-gamma and IL-2. Pre-challenge and pre-depletion titers of neutralizing Ab correlated inversely with peaks of viremia and directly with peaks for anti-viral CD4 cells. Thus, our results reveal CD8 cells playing a central role, and neutralizing Ab, a supporting role in SHIV-89.6P control. They also suggest a dynamic relationship between neutralizing Ab, antigen load and anti-viral CD4 cells in the maturation of high-quality anti-viral CD8 T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185742     DOI: 10.1016/j.virol.2005.08.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

2.  CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads.

Authors:  Yvonne M Mueller; Duc H Do; Jean D Boyer; Muhamuda Kader; Joseph J Mattapallil; Mark G Lewis; David B Weiner; Peter D Katsikis
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

3.  Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.

Authors:  Yun Li; Bradley Cleveland; Igor Klots; Bruce Travis; Barbra A Richardson; David Anderson; David Montefiori; Patricia Polacino; Shiu-Lok Hu
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

4.  Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.

Authors:  Thaidra Gaufin; Ruy M Ribeiro; Rajeev Gautam; Jason Dufour; Daniel Mandell; Cristian Apetrei; Ivona Pandrea
Journal:  Retrovirology       Date:  2010-05-11       Impact factor: 4.602

5.  Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions.

Authors:  Juan García-Arriaza; José Luis Nájera; Carmen E Gómez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

6.  Expansion and exhaustion of T-cell responses during mutational escape from long-term viral control in two DNA/modified vaccinia virus Ankara-vaccinated and simian-human immunodeficiency virus SHIV-89.6P-challenged macaques.

Authors:  Shanmugalakshmi Sadagopal; Rama Rao Amara; Sunil Kannanganat; Sunita Sharma; Lakshmi Chennareddi; Harriet L Robinson
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

7.  Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Ronald S Veazey; Paula M Acierno; Kimberly J McEvers; Susanne H C Baumeister; Gabriel J Foster; Melisa D Rett; Michael H Newberg; Marcelo J Kuroda; Kenneth Williams; Eun-Young Kim; Steven M Wolinsky; E Peter Rieber; Michael Piatak; Jeffrey D Lifson; David C Montefiori; Charles R Brown; Vanessa M Hirsch; Jörn E Schmitz
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

8.  Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.

Authors:  Ilnour Ourmanov; Takeo Kuwata; Robert Goeken; Simoy Goldstein; Ranjani Iyengar; Alicia Buckler-White; Bernard Lafont; Vanessa M Hirsch
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

9.  Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.

Authors:  John Schell; Nina F Rose; Nicole Fazo; Preston A Marx; Meredith Hunter; Elizabeth Ramsburg; David Montefiori; Patricia Earl; Bernard Moss; John K Rose
Journal:  Vaccine       Date:  2009-01-07       Impact factor: 3.641

10.  HIV vaccination: turning the spotlight on effector memory T cells as mucosal gatekeepers.

Authors:  Hilde Cheroutre
Journal:  F1000 Biol Rep       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.